Issn Print: 0036-8075
Publication Date: 2017/09/01
Influence, integrity, and the FDA: An ethical framework
Spencer Phillips Hey; I. Glenn Cohen; Eli Y. Adashi; Aaron S. Kesselheim
Author Information: Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.